Stay updated on Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Sign up to get notified when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.

Latest updates to the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, reflecting a minor version update to the page rendering. It represents a metadata change rather than a modification to study content.SummaryDifference0.0%

- Check22 days agoChange DetectedA Related Info section was added, showing sponsor-related context such as Boehringer Ingelheim and a 'Helpful Links Provided by' entry. The new content also includes drug and device information, study documents, and helpful links as part of the Related Info area.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page displays Revision: v3.6.5, indicating a new site version.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page footer now shows Revision: v3.6.4 instead of v3.6.3, indicating a backend/frontend update with no direct impact to the study details displayed.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page’s revision tag was updated to v3.6.3, replacing the previous v3.6.2 tag, indicating a minor update to the page’s revision history.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2 on the page. No study content or behavior is affected.SummaryDifference0.0%

Stay in the know with updates to Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.